Found: 6
Select item for more details and to access through your institution.
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.
- Published in:
- Schizophrenia Bulletin, 2024, v. 50, n. 3, p. 496, doi. 10.1093/schbul/sbae011
- By:
- Publication type:
- Article
Affinity scores: An individual-centric fingerprinting framework for neuropsychiatric disorders.
- Published in:
- Translational Psychiatry, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41398-022-02084-9
- By:
- Publication type:
- Article
Cognitive behavioral markers of neurodevelopmental trajectories in rodents.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-021-01662-7
- By:
- Publication type:
- Article
Disruptions in white matter microstructure associated with impaired visual associative memory in schizophrenia-spectrum illness.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2022, v. 272, n. 6, p. 971, doi. 10.1007/s00406-021-01333-0
- By:
- Publication type:
- Article
Investigation of structural brain correlates of neurological soft signs in individuals at ultra-high risk for psychosis.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2021, v. 271, n. 8, p. 1475, doi. 10.1007/s00406-021-01300-9
- By:
- Publication type:
- Article
The self, neuroscience and psychosis study: Testing a neurophenomenological model of the onset of psychosis.
- Published in:
- Early Intervention in Psychiatry, 2024, v. 18, n. 2, p. 153, doi. 10.1111/eip.13448
- By:
- Publication type:
- Article